PPARG and cancer: As the canonical Wnt/β-catenin signaling pathway plays a crucial role in the development of cancer through chronic inflammation, non-steroidal anti-inflammatory drugs, such as PPARγ agonists, might serve as potent therapeutic agents to treat cancers as they inhibit the Wnt/β-catenin pathway36,37.